CNBC: New year, new investing strategy?

EquityZen

|

December 23, 2015

Company News

EquityZen's managed fund offering is featured by CNBC as a tool for accredited investors to diversify their exposure to private technology companies.

Related Posts

Company News

EquityZen | April 14, 2021

Yahoo Finance: Coinbase's direct listing and what to expect as a crypto investor

EquityZen's Phil Haslett joins Yahoo Finance to talk crypto, direct listings, and the growth of the pre-IPO market.

Company News

EquityZen | August 9, 2024

Kiplinger: Is Pre-IPO Investing Worth the Risk of Getting Burned?

Kiplinger shares how returns for investors who get in before companies go public can be white-hot. But you'd better be...

Company News

Phil Haslett | January 2, 2024

Inc.: Companies Want to Go Public, But Aren't Ready to Pull The Trigger

New Year, new IPO market? The first quarter of 2024 will be an important indictor of what's to come for the remainder...

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen. All rights reserved.